Abstract:The pharmacokinetics of doxycycline hydrochloride (CAS 24390-14-5) was investigated In 11 healthy Chinese volunteers after single- and multiple-dose Intravenous (i. v.) Infusion. This study was conducted according to an open, randomized, four-period design with a one-week washout period separating each trial period. Single-dose studies with 100, 200, and 300 mg doxycycline were performed in the first three periods by a replicated 3 x 3 Latin square crossover design. Multiple-dose studies with once-daily 100 mg doxycycline for 7 consecutive days were performed in the last treatment period.Blood samples for pharmacokinetic profiling were taken up to 48 It post-infusion. Doxycycline hydrochloride plasma concentrations were determined with a validated liquid chromatography-ultraviolet (HPLC-UV) method. The pharmacokinetic parameters for single- and multiple-dose administration were estimated as follows: Maximum plasma concentrations (C-max) amounted to 1.49 +/- 0.59 mu g/mL (single, 100 mg doxycycline), 4.20 +/- 1.34 mu g/mL (single, 200 mg doxycycline), 6.69 +/- 1.26 mu g/mL (single-dose, 300 mg doxycycline) and 3.05 +/- 0.92 mu g/mL (multiple-dose, 100 mg doxycycline). The median T-max (2 h of infusion Included) was 2.00 +/- 0.19 h, 1.93 +/- 0.23 h, and 1.98 +/- 0.18 h for single dose of 100 mg, 200 mg, 300 mg doxycycline and 2.11 +/- 0.17 h for multiple dose of 100 mg doxycycline, respectively. Plasma elimination half-lives (t(1/2)) were 14.00 +/- 5.88 h, 14.20 +/- 8.11 h, 16.66 +/- 7.12 h and 14.03 +/- 3.50 h, areas under the plasma concentration-time curve (AUC(0-infinity)) were 21.85 +/- 6.37 mu g.h/mL, 52.02 +/- 15.26 mu g.h/mL, 84.86 +/- 23.03 mu g.h/mL and 34.64 +/- 5.89 mu g.h/mL, AUC(0-48) were 19.75 +/- 6.60 mu g.h/mL, 46.13 +/- 12.21 mu g.h/mL, 75.57 +/- 20.31 mu g.h/mL and 32.03 +/- 5.70 mu g.h/mL, for single dose of 100, 200, 300 mg doxycyctine and multiple dose of 100 mg doxycycline, respectively. AUC In the single-dose study were dose proportional, doxycycline hydrochloride showed first order kinetics in the range of 100-300 mg. The plasma concentration of doxycycline hydrochloride has been sustained at a certain effective level after multiple-dose treatment, and the elimination process was similar to that after the single dose. Gender differences were also observed.

Pharmacokinetics of Thiamphenicol Glycinate and Its Active Metabolite by Single and Multiple Intravenous Infusions in Healthy Chinese Volunteers.

Simultaneous analysis of thiamphenicol and its prodrug thiamphenicol glycinate in human plasma and urine by high performance liquid chromatography: application to pharmacokinetic study.

Determination of Tigecycline in Human Plasma by LC-MS/MS and Its Application to Population Pharmacokinetics Study in Chinese Patients with Hospital-Acquired Pneumonia.

Simultaneous determination of thiamphenicol and its prodrug thiamphenicol glycinate in human plasma by high performance liquid chromatography

Pharmacokinetics of the Prodrug Thiamphenicol Glycinate and Its Active Parent Compound Thiamphenicol in Beagle Dogs Following Intravenous Administration

Pharmacokinetics of Tenofovir Disoproxil Fumarate Tablets in Healthy Volunteers from Western China

Therapeutic Drug Monitoring of Tigecycline in 67 Infected Patients and a Population Pharmacokinetics/Microbiological Evaluation of A. baumannii Study

Development and validation of an LC-MS/MS method for the determination of tigecycline in human plasma and cerebrospinal fluid and its application to a pharmacokinetic study

Pharmacokinetics of minocycline hydrochloride in Chinese healthy volunteers

HPLC determination of thiamphenicol in human plasma its pharmacokinetics in Chinese volunteers

Pharmacokinetics of Cefepime Injection after a Single Dose in Chinese Healthy Korean and Han Volunteers

Pharmacokinetics, Safety, and Tolerability of Amygdalin and Paeoniflorin after Single and Multiple Intravenous Infusions of Huoxue-Tongluo Lyophilized Powder for Injection in Healthy Chinese Volunteers.

Pharmacokinetic Study of Cefotetan Disodium for Injection in Chinese Healthy Volunteers

Pharmacokinetics of Compound Telmisartan Tablets in Chinese Healthy Volunteers

Simultaneous determination of BGT-002 and its acyl glucuronide metabolite ZM326E-M2 in human plasma by liquid chromatography-tandem mass spectrometry and its application to a pharmacokinetic study

Quantitative analysis and pharmacokinetics study of tigecycline in human serum using a validated sensitive liquid chromatography with tandem mass spectrometry method.

Determination of Tigecycline in Human Lung Epithelial Cells and Polymorphonuclear Neutrophils by Liquid Chromatography/tandem Mass Spectrometry and Its Application in a Cellular Pharmacokinetics Study

Tolerability and Pharmacokinetics of Biapenem Following Single and Multiple Intravenous Administrations in Healthy Chinese Subjects: an Open-Label, Randomized, Single-Center Study.

Pharmacokinetics of Doxycycline Hydrochloride Administered by Intravenous Infusion in Healthy Chinese Volunteers

A First-in-human Safety, Tolerability and Pharmacokinetics study of Benapenem in Healthy Chinese Volunteers.

Determination of Plasma Concentration of Vitamin E Nicotinate and Its Pharmacokinetics in Healthy Chinese Volunteers